Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms

Thromb Res. 2018 Jul:167:57-59. doi: 10.1016/j.thromres.2018.05.014. Epub 2018 May 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / complications*
  • Myeloproliferative Disorders / pathology
  • Thrombosis / chemically induced*
  • Thrombosis / pathology

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors